ArticleCancers2025

Evaluating Therapeutic Efficacy of the Vascular Disrupting Agent OXi8007 Against Kidney Cancer in Mice.

Hashini I Wanniarachchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.